Ribosomal protein L29 pseudogene 20 (RPL29P20)

RPL29P20 (Ribosomal protein L29 pseudogene 20) is classified as a pseudogene, meaning it is a DNA sequence nearly identical to that of the functional RPL29 gene but is not transcribed into a functional protein[4]. Pseudogenes typically arise from gene duplication or retrotransposition events but accumulate mutations that render them non-functional. There is no evidence that RPL29P20 encodes a protein or participates directly in any biological function, nor is it recognized as a druggable or therapeutic target. RPL29P20 does not have documented disease associations, interacting drugs, or biomarker potential. For scientific and therapeutic purposes, RPL29P20 should not be considered an active molecular target[4].